Thanks for stopping by the Clarivate booth at BioTechX USA in Philadelphia.

After providing your details you will get access to all this insightful content.

Blog posts/Press releases

• Indication Expansion: Pioneering new uses for existing cancer drugs
• Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence

On-demand webinars

• Informed Risk Assessment – leveraging preclinical safety intelligence to anticipate clinical adverse events
• Old drugs, new life: Harnessing Drug Repurposing for Breakthrough Treatments

Case studies

• Making early detection of ovarian cancer a reality – Cortellis Drug Discovery Intelligence Case study
• Assessing the potential of PROTACs as treatments for Alzheimer’s disease – Cortellis Drug Discovery Intelligence Case study
• Optimizing Dosing with AI/ML Driven Transdermal Dosing – VeriSIM Life Case study
• Identifying plausible targets/mechanisms behind adverse events – OFF_X Case study
• Building an ML model to identify undiagnosed patients with rare disease – Case study

Reports/Whitepapers

• Best practices in toxicology Future-proofing drug discovery and preclinical development through effective toxicity testing
• Cracking the code: Generating and validating hypotheses for target identification
• Prioritize indications at scale
• The challenges of working with real world data and key ways to overcome them – Report
• Applying machine learning to real-world data in rare disease – Whitepaper

Fact Sheets

• Cortellis Drug Discovery Intelligence – Factsheet
• VeriSIM – Factsheet
• OFF-X – Preclinical Safety – Fact Sheet
• OFF-X Clinical Research- Fact Sheet

Presentations

• Analyze molecular pathways and accelerate discovery research – MetaCore, MetaBase and Key Pathway Advisor
• Target Identification & Drug Repurposing – Drug translational sciences